Army Looks To Biofeedback, Yoga, And Acupuncture To Treat Pain
Archives
All entries, chronologically...
A new multi-center study, including neurologists and neurosurgeons from the Perelman School of Medicine at the University of Pennsylvania, reveals that Deep Brain Stimulation (DBS) – a treatment for Parkinson’s disease (PD) patients with medication-resistant muscle movement impairment or tremors – can improve those symptoms and reduce medications for patients implanted with the device. The study appears Online First in Lancet Neurology.
A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives of Neurology, one of the JAMA/Archives journals. The study was completed by Thomas M. van Himbergen, Ph.D., from the Lipid Metabolism Laboratory, Human Nutrition Research Center on Aging, Tufts University, Boston, and colleagues.
People with diets high in several vitamins or in omega 3 fatty acids are less likely to have the brain shrinkage associated with Alzheimer’s disease than people whose diets are not high in those nutrients, according to a new study published in the December 28, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology. The study author was Gene Bowman, ND, MPH, of Oregon Health & Science University in Portland, and a member of the American Academy of Neurology.
New research suggests that, in people who do not currently have memory problems, those with smaller regions of the brain’s cortex may be more likely to develop symptoms consistent with very early Alzheimer’s disease. The study is published in the December 21, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.
Patients with Parkinson disease-related dementia appear to have increased brain atrophy in the hippocampal, temporal and parietal lobes and decreased prefrontal cortex volume compared to patients with Parkinson disease without dementia, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archivesjournals. The study was conducted by Daniel Weintraub, M.D., of the Perelman School of Medicine, University of Pennsylvania, Philadelphia, and colleagues.
Before she could seek to convince the world that her computer model of a key brain circuit explains a fundamental, 80-year-old mystery of neuroscience with potential relevance to Parkinson’s disease, Stephanie Jones sought to convince Christopher Moore. The new Brown neuroscience professors are now close collaborators, but when they first started talking about the beta oscillations of the cortex, Moore thought Jones was plain wrong, if not a bit nuts.
On the quest for safe, reliable and accessible tools to accurately diagnose Alzheimer’s disease, researchers from the Perelman School of Medicine at the University of Pennsylvania found a new way of diagnosing and tracking Alzheimer’s disease, using an innovative magnetic resonance imaging (MRI) technique called Arterial spin labeling (ASL) to measure changes in brain function. The team determined that the ASL-MRI test is a promising alternative to the current standard, a specific PET scan that requires exposure to small amounts of a radioactive glucose analog and costs approximately four-times more than an ASL-MRI.
A 22-year-old woman known as “HC” with amnesia since birth as a result of developing only half the normal volume of the hippocampus in her brain, has demonstrated to scientists that the ability to hold a single face or word in short-term memory is impaired. Included in this report is a video summary of the study results.
Depression is one of the most common mental disorders in the elderly, but little is known about the underlying biology of its development in older adults. In a small study published in the November issue of the peer-reviewed journal Archives of General Psychiatry, UCLA researchers used a unique brain scan to assess the levels of amyloid plaques and tau tangles in older adults with a type of severe depression called major depressive disorder (MDD).
Scientists outline new methods for better understanding links between specific proteins and the risks associated with Alzheimer’s disease in an article co-authored by University of Alabama researchers and publishing today in Science Express. In experiments using a series of model organisms, including yeast, microscopic roundworms and rats, the researchers show how basic mechanisms inside cells are disrupted when a specific human protein, known as the amyloid beta peptide, fails to properly fold.
